Evidence map›Paper›PMID 24039264›Full record

ArticleJournal of bacteriology2013

The second messenger cyclic Di-GMP regulates Clostridium difficile toxin production by controlling expression of sigD.

Robert W McKee, Mihnea R Mangalea, Erin B Purcell, Erin K Borchardt, Rita Tamayo

Open access · greenAbstract read
In one paragraph

Article in Journal of bacteriology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 91 papers.

0numbers the graph read from it
0cells of the map it votes in
91citing papers in PubMed
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

91 citing papers in PubMed, 130 citations in OpenAlex.

  1. A programmed reset mechanism primesScience advances · 2026
    Article
  2. Review
  3. Article
  4. Dissecting the role of flagellar subunits inJournal of bacteriology · 2025
    Article
  5. Article
  6. Biofilm Dispersal inMicroorganisms · 2025
    Article
  7. Review
  8. Article
  9. The current riboswitch landscape inMicrobiology (Reading, England) · 2024
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. International journal of molecular sciences · 2024
    Review
  15. Butyrate enhancesJournal of bacteriology · 2023
    Article
  16. Biofilm Formation ofMicroorganisms · 2023
    Review
  17. Review
  18. Regulatory transcription factors ofCritical reviews in microbiology · 2023
    Review
  19. Article
  20. Article

31 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Robert W McKeeDepartment of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Mihnea R Mangalea
Erin B Purcell
Erin K Borchardt
Rita Tamayo
University of North Carolina at Chapel Hill · US

Funding

Yessinia autotransporters (Yaps): Structure, function, and host responseU54AI057157 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SEMPOWSKI, GREGORY D · 2003 to 2013
$91.4M
GASTROENTEROLOGY RESEARCH TRAININGT32DK007737 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SHEHZAD Z. SHEIKH · 1996 to 2026
$7.8M
Regulation of Clostridium difficile Colonization FactorsR01AI107029 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI TAMAYO, RITA · 2013 to 2022
$3.9M
Phase variation of virulence factors in Clostridioides difficileR37AI107029 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI RITA TAMAYO · 2025 to 2026
$1.0M
NIAID NIH HHS R01 AI107029NIAID NIH HHS R01AI107029NIAID NIH HHS R37 AI107029NIAID NIH HHS U54 AI057157NIAID NIH HHS U54AI057157NIDDK NIH HHS T32 DK007737NIDDK NIH HHS T32DK007737
6 · The paper itself

Abstract

The Gram-positive obligate anaerobe Clostridium difficile causes potentially fatal intestinal diseases. How this organism regulates virulence gene expression is poorly understood. In many bacterial species, the second messenger cyclic di-GMP (c-di-GMP) negatively regulates flagellar motility and, in some cases, virulence. c-di-GMP was previously shown to repress motility of C. difficile. Recent evidence indicates that flagellar gene expression is tightly linked with expression of the genes encoding the two C. difficile toxins TcdA and TcdB, which are key virulence factors for this pathogen. Here, the effect of c-di-GMP on expression of the toxin genes tcdA and tcdB was determined, and the mechanism connecting flagellar and toxin gene expressions was examined. In C. difficile, increasing c-di-GMP levels reduced the expression levels of tcdA and tcdB, as well as that of tcdR, which encodes an alternative sigma factor that activates tcdA and tcdB expression. We hypothesized that the C. difficile orthologue of the flagellar alternative sigma factor SigD (FliA; σ(28)) mediates regulation of toxin gene expression in response to c-di-GMP. Indeed, ectopic expression of sigD in C. difficile resulted in increased expression levels of tcdR, tcdA, and tcdB. Furthermore, sigD expression enhanced toxin production and increased the cytopathic effect of C. difficile on cultured fibroblasts. Finally, evidence is provided that SigD directly activates tcdR expression and that SigD cannot activate tcdA or tcdB expression independent of TcdR. Taken together, these data suggest that SigD positively regulates toxin genes in C. difficile and that c-di-GMP can inhibit both motility and toxin production via SigD, making this signaling molecule a key virulence gene regulator in C. difficile.

Indexed as

Gene Expression Regulation, BacterialBacterial ProteinsBacterial ToxinsClostridioides difficileCyclic GMPEnterotoxinsSigma FactorBacterial ProteinsBacterial Toxinsbis(3',5')-cyclic diguanylic acidCyclic GMPEnterotoxinsSigma FactortcdA protein, Clostridium difficiletoxB protein, Clostridium difficile

Identifiers

PMID24039264
PMCPMC3811590
OpenAlexW2171079736

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.